Search research articles
Contact Us
Filters
Showing results (181-190 of 273) with videos related to
Page
of 28
Sort By:
Leukemia
|
November 1, 2024
Post-transplant cyclophosphamide separates graft-versus host disease and graft versus leukemia effects after HLA-matched stem-cell transplantation for acute myeloid leukemia
Avichai Shimoni, Christophe Peczynski, Myriam Labopin, et al.
Mycoses
|
August 27, 2016
Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant
Carlos Solano, Monica Slavin, Alissa J Shaul, et al.
Annals of Hematology
|
July 19, 2018
PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation
Nazly Santos, Rocío Rodríguez-Romanos, Rafael de la Cámara, et al.
Blood Advances
|
December 14, 2021
Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19
José Luis Piñana, Ramon Garcia-Sanz, Rodrigo Martino, et al.
Transplantation and Cellular Therapy
|
March 27, 2026
Transportability to the European population of Efficacy of Belumosudil as Compared with Physician's Choice of Best Available Therapy for The Treatment of Chronic Graft Versus Host Disease
Daniel Wolff, Carlos Solano, David Michonneau, et al.
Transplantation and Cellular Therapy
|
June 14, 2025
Corrigendum to: "Comparison of three strategies of GvHD prophylaxis after T-cell replete haploidentical hematopoietic transplantation: Tacrolimus vs calcineurin inhibitors-MMF vs sirolimus-MMF" Journal: Transplant Cell Ther. 2024 Oct;30(10):1025.e1-1025.e14. doi: 10.1016/j.jtct.2024.07.027
Albert Esquirol, Maria Jesus Pascual, Juan Montoro, et al.
Transplantation and Cellular Therapy
|
August 8, 2024
Comparison of Three Graft-versus-Host Disease Prophylaxis Strategies after T Cell-Replete Haploidentical Hematopoietic Transplantation: Tacrolimus versus Calcineurin Inhibitors + Mycophenolate Mofetil versus Sirolimus + Mycophenolate Mofetil
Albert Esquirol, Maria Jesus Pascual, Juan Montoro, et al.
The Journal of Infection
|
January 14, 2020
Clinical significance of Pneumocystis jirovecii DNA detection by real-time PCR in hematological patient respiratory specimens
José Luis Piñana, Eliseo Albert, María Dolores Gómez, et al.
The Journal of Infection
|
February 25, 2019
Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: Implications for the diagnosis of CMV pneumonia
José Luis Piñana, Estela Giménez, María Dolores Gómez, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
April 12, 2017
Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis
Bonaventura Casanova, Isidro Jarque, Francisco Gascón, et al.
Page
of 28
Search research articles
Search
Showing results (181-190 of 273) with videos related to
Sort By:
Page
of 28
Leukemia
|
November 1, 2024
Post-transplant cyclophosphamide separates graft-versus host disease and graft versus leukemia effects after HLA-matched stem-cell transplantation for acute myeloid leukemia
Avichai Shimoni, Christophe Peczynski, Myriam Labopin, et al.
Mycoses
|
August 27, 2016
Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant
Carlos Solano, Monica Slavin, Alissa J Shaul, et al.
Annals of Hematology
|
July 19, 2018
PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation
Nazly Santos, Rocío Rodríguez-Romanos, Rafael de la Cámara, et al.
Blood Advances
|
December 14, 2021
Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19
José Luis Piñana, Ramon Garcia-Sanz, Rodrigo Martino, et al.
Transplantation and Cellular Therapy
|
March 27, 2026
Transportability to the European population of Efficacy of Belumosudil as Compared with Physician's Choice of Best Available Therapy for The Treatment of Chronic Graft Versus Host Disease
Daniel Wolff, Carlos Solano, David Michonneau, et al.
Transplantation and Cellular Therapy
|
June 14, 2025
Corrigendum to: "Comparison of three strategies of GvHD prophylaxis after T-cell replete haploidentical hematopoietic transplantation: Tacrolimus vs calcineurin inhibitors-MMF vs sirolimus-MMF" Journal: Transplant Cell Ther. 2024 Oct;30(10):1025.e1-1025.e14. doi: 10.1016/j.jtct.2024.07.027
Albert Esquirol, Maria Jesus Pascual, Juan Montoro, et al.
Transplantation and Cellular Therapy
|
August 8, 2024
Comparison of Three Graft-versus-Host Disease Prophylaxis Strategies after T Cell-Replete Haploidentical Hematopoietic Transplantation: Tacrolimus versus Calcineurin Inhibitors + Mycophenolate Mofetil versus Sirolimus + Mycophenolate Mofetil
Albert Esquirol, Maria Jesus Pascual, Juan Montoro, et al.
The Journal of Infection
|
January 14, 2020
Clinical significance of Pneumocystis jirovecii DNA detection by real-time PCR in hematological patient respiratory specimens
José Luis Piñana, Eliseo Albert, María Dolores Gómez, et al.
The Journal of Infection
|
February 25, 2019
Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: Implications for the diagnosis of CMV pneumonia
José Luis Piñana, Estela Giménez, María Dolores Gómez, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
April 12, 2017
Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis
Bonaventura Casanova, Isidro Jarque, Francisco Gascón, et al.
Page
of 28